Advanced Filters
noise
Found 1,651 clinical trials

Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes

Type 2 diabetes is a risk factor of heart failure and cognitive decline. Heart failure at its early stage is often silent. At present, primary prevention for heart failure is not available. Our aim is to identify diabetic patients at risk of heart failure in order to develop personalized preventive …

18 years of age All Phase N/A
I Ildar Fakhradiyev, PhD

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.

18 - 69 years of age All Phase N/A
B Beilei Wang, M.D.

Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)

Pancreatic cancer is one of the most fatal malignancies with a 5-year survival rate of only ~6%[1]. The reasons for this high mortality rate can be attributed to several factors, of which perhaps the most important is delayed diagnosis due to vague symptoms and consequently missed opportunities for surgical resection. …

50 - 75 years of age All Phase N/A
A Ammara Mushtaq, MD

Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility

SWIFT-CORE-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, comorbidities, and current symptoms. Site staff may collect vital signs, urine drug screens, …

18 years of age All Phase N/A
X Xiu Qiu, MD,PhD

Human Genes and Microbiota in Early Life

The long-term goal of the Human Genes and Microbiota in Early Life (HuGME) is to explore the short- and long-term effects of maternal microbiota during pregnancy and the microbiota colonization of their offspring early in life and their interaction with the host on maternal-offspring health consequences in later life in …

years of age All Phase N/A
A Andreea Valdman, MD

Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure

The goal of this clinical investigation is to explore a non-invasive technology for measuring the microcirculatory structure, composition and function in patients from a primary care population. The main aims are: To evaluate the robustness of the technology for assessment of the molecular composition and structure of the skin tissue …

18 years of age All Phase N/A
A Andreea Valdman, MD

Vibrometer Based Pulse Wave Analysis for Arterial Stiffness and Ischemic Heart Disease Risk Assessment

This clinical investigation will evaluate a novel contactless technology for assessing arterial stiffness and explore its potential in assessment of risk for and development of cardiovascular disease. The main aims of the study are: To assess device and method performance for assessment of arterial stiffness and cardiovascular risk, on a …

18 years of age All Phase N/A
F Fabian Ferroni, MD

Cardiometabolic Risk Factors Registry

CARFARE (CARDIOMETABOLIC RISK FACTORS REGISTRY) is a registry done in the context of a cardiovascular primary prevention program of the Cardiometabolic Unit Officia of the Cardiology Department of the Austral University Hospital. The structured and sequential evaluation include measurement of anthropometric parameters (body mass index, BMI), laboratory with metabolic profile, …

18 years of age All Phase N/A

Global Research Initiative for Patients Screening on MASH

GRIPonMASH will assist (primary) health care providers clinicians to implement the latest patient care pathway, as described by the European Association for the Study of the Liver (EASL), to identify patients at risk of severe metabolic dysfunction-associated steatotic liver disease (MASLD) and to raise awareness. The primary objective is to …

18 - 75 years of age All Phase N/A
N Nicolas Renna, MD

Argentine Registry of Lp(a)

The Argentine Registry on Lipoprotein(a) (LP(a)), orchestrated by the Argentine Group for LP(a) Study, stands as a pioneering and extensive prospective initiative. This registry systematically collects geolocation data, including patient postal codes, demographic information, and a multifaceted array of health parameters to unravel the intricate associations surrounding LP(a) levels. The …

18 years of age All Phase N/A

Simplify language using AI